- Release Date: 24/06/19 09:55
- Summary: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
- Price Sensitive: Yes
- Download Document 134.93KB
Ann: FDA Grants Revascor Orphan Drug For End Stage CHF With LVADs
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$2.32 |
Change
0.025(1.09%) |
Mkt cap ! $2.931B | |||
| Open | High | Low | Value | Volume |
| $2.31 | $2.33 | $2.31 | $807.2K | 348.3K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 10 | 13475 | $2.31 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $2.32 | 31945 | 14 |
View Market Depth
| Last trade - 10.07am 13/08/2025 (20 minute delay) ? |
| MSB (ASX) Chart |